Literature DB >> 13680463

Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors.

Sharon L Naismith1, Ian B Hickie, Keelin Turner, Craig L Little, Virginia Winter, Philip B Ward, Kay Wilhelm, Philip Mitchell, Gordon Parker.   

Abstract

The present study explores neuropsychological functioning in patients with depression with reference to key clinical, etiological and genetic features. In comparison to healthy volunteers, patients with severe depression demonstrated poorer performance on all neuropsychological tests except for WAIS-R Vocabulary and a 64-item computerized version of the Wisconsin Card Sorting Test. On average, patients exhibited significant impairments (greater than -2 standard deviation units) on tests of simple reaction time, Part B of the Trail Making Test and Raven's Colored Progressive Matrices. When performance decrements were analyzed with reference to key clinical features, patients with melancholia performed more poorly on WAIS-R Vocabulary, semantic fluency and choice reaction time than those with nonmelancholic depression. After controlling for age, those patients with late-onset depression (i.e., age of onset > or =50 years) exhibited poorer performance on a computerized version of the Tower of London test in comparison to those with an early onset. While there was no relationship between neuropsychological test scores and summed vascular risk factors or apolipoprotein E genotypes, presence of the methylenetetrahydrofolate reductase gene mutation was associated with slowed reaction time. The differential relationships between clinical, etiological and genetic risks and neuropsychological performance supports the presence of unique pathophysiological mechanisms in distinct subgroups of patients. These findings underscore the need to consider subtypes when investigating neuropsychological deficits in patients with depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680463     DOI: 10.1076/jcen.25.6.866.16472

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  34 in total

Review 1.  Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder.

Authors:  Jonathan B Savitz; Mark Solms; Rajkumar S Ramesar
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Soluble amyloid-β levels and late-life depression.

Authors:  Ricardo S Osorio; Tyler Gumb; Nunzio Pomara
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

4.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

5.  Changes in cognitive function from presurgery to 4 months postsurgery in individuals undergoing dysvascular amputation.

Authors:  Rhonda M Williams; Aaron P Turner; Monica Green; Daniel C Norvell; Alison W Henderson; Kevin N Hakimi; Donna J Blake; Joseph M Czerniecki
Journal:  Arch Phys Med Rehabil       Date:  2013-12-04       Impact factor: 3.966

6.  Executive functions in elderly men.

Authors:  Mu-En Liu; Yun-Hsuan Chang; Yan-Chiou Ku; Sheng-Yu Lee; Chih-Chung Huang; Shiou-Lan Chen; Shih-Heng Chen; Chun-Hsien Chu; Wen-Chien Liu; Ru-Band Lu
Journal:  Age (Dordr)       Date:  2011-02-19

7.  Neuropsychological and hypothalamic-pituitary-axis function in female patients with melancholic and non-melancholic depression.

Authors:  Ioannis Michopoulos; Iannis M Zervas; Chris Pantelis; Eleftheria Tsaltas; Vassiliki-Maria Papakosta; Fotini Boufidou; Chrissoula Nikolaou; Charalambos Papageorgiou; Costas R Soldatos; Lefteris Lykouras
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

8.  Neuropsychological deficits in major depression reflect genetic/familial risk more than clinical history: a monozygotic discordant twin-pair study.

Authors:  Kean J Hsu; Kelly C Young-Wolff; Kenneth S Kendler; Lisa J Halberstadt; Carol A Prescott
Journal:  Psychiatry Res       Date:  2013-11-05       Impact factor: 3.222

9.  Childhood-onset HAM/TSP with progressive cognitive impairment.

Authors:  Giovanna Zorzi; Roberta Mancuso; Nardo Nardocci; Laura Farina; Franca Rosa Guerini; Pasquale Ferrante
Journal:  Neurol Sci       Date:  2010-04       Impact factor: 3.307

10.  Cognitive functioning in major depression--a summary.

Authors:  Asa Hammar; Guro Ardal
Journal:  Front Hum Neurosci       Date:  2009-09-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.